BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31693753)

  • 1. Two negatively charged invariant residues influence ligand binding and conformational dynamics of 14-3-3ζ.
    Modi K; Dalvi S; Venkatraman P
    FEBS Lett; 2020 Mar; 594(5):878-886. PubMed ID: 31693753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights on the effects of mutation of a charged binding pocket residue on phosphopeptide binding to 14-3-3ζ protein.
    T S S; Dalvi S; Venkatraman P; Vemparala S
    Proteins; 2022 May; 90(5):1179-1189. PubMed ID: 35006623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Analysis of the 14-3-3ζ/Chibby Interaction Involved in Wnt/β-Catenin Signaling.
    Killoran RC; Fan J; Yang D; Shilton BH; Choy WY
    PLoS One; 2015; 10(4):e0123934. PubMed ID: 25909186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peripheral binding of 14-3-3γ to membranes involves isoform-specific histidine residues.
    Bustad HJ; Skjaerven L; Ying M; Halskau Ø; Baumann A; Rodriguez-Larrea D; Costas M; Underhaug J; Sanchez-Ruiz JM; Martinez A
    PLoS One; 2012; 7(11):e49671. PubMed ID: 23189152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 protein C-terminal stretch occupies ligand binding groove and is displaced by phosphopeptide binding.
    Silhan J; Obsilova V; Vecer J; Herman P; Sulc M; Teisinger J; Obsil T
    J Biol Chem; 2004 Nov; 279(47):49113-9. PubMed ID: 15347690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of a yeast 14-3-3 protein from Lachancea thermotolerans in the unliganded form and bound to a human lipid kinase PI4KB-derived peptide reveal high evolutionary conservation.
    Eisenreichova A; Klima M; Boura E
    Acta Crystallogr F Struct Biol Commun; 2016 Nov; 72(Pt 11):799-803. PubMed ID: 27827352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for protein-protein interactions in the 14-3-3 protein family.
    Yang X; Lee WH; Sobott F; Papagrigoriou E; Robinson CV; Grossmann JG; Sundström M; Doyle DA; Elkins JM
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17237-42. PubMed ID: 17085597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms.
    Gardino AK; Smerdon SJ; Yaffe MB
    Semin Cancer Biol; 2006 Jun; 16(3):173-82. PubMed ID: 16678437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR spectroscopy of 14-3-3ζ reveals a flexible C-terminal extension: differentiation of the chaperone and phosphoserine-binding activities of 14-3-3ζ.
    Williams DM; Ecroyd H; Goodwin KL; Dai H; Fu H; Woodcock JM; Zhang L; Carver JA
    Biochem J; 2011 Aug; 437(3):493-503. PubMed ID: 21554249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening.
    Sijbesma E; Skora L; Leysen S; Brunsveld L; Koch U; Nussbaumer P; Jahnke W; Ottmann C
    Biochemistry; 2017 Aug; 56(30):3972-3982. PubMed ID: 28681606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 protein binding blocks the dimerization interface of caspase-2.
    Kalabova D; Filandr F; Alblova M; Petrvalska O; Horvath M; Man P; Obsil T; Obsilova V
    FEBS J; 2020 Aug; 287(16):3494-3510. PubMed ID: 31961068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein modeling combined with spectroscopic techniques: an attractive quick alternative to obtain structural information.
    Kubala M; Obsil T; Obsilová V; Lánský Z; Amler E
    Physiol Res; 2004; 53 Suppl 1():S187-97. PubMed ID: 15119949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the 14-3-3ζ-LKB1 fusion protein provides insight into a novel ligand-binding mode of 14-3-3.
    Ding S; Zhou R; Zhu Y
    Acta Crystallogr F Struct Biol Commun; 2015 Sep; 71(Pt 9):1114-9. PubMed ID: 26323294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of hydrogen/deuterium exchange or chemical cross-linking techniques with mass spectrometry: mapping of human 14-3-3ζ homodimer interface.
    Haladová K; Mrázek H; Ječmen T; Halada P; Man P; Novák P; Chmelík J; Obšil T; Šulc M
    J Struct Biol; 2012 Jul; 179(1):10-7. PubMed ID: 22580067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis for the Interaction of a Human Small Heat Shock Protein with the 14-3-3 Universal Signaling Regulator.
    Sluchanko NN; Beelen S; Kulikova AA; Weeks SD; Antson AA; Gusev NB; Strelkov SV
    Structure; 2017 Feb; 25(2):305-316. PubMed ID: 28089448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between a negatively charged ligand and the electronegative binding pocket of its receptor.
    Huang HC; Briggs JM
    Biopolymers; 2002 Apr; 63(4):247-60. PubMed ID: 11807752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine Modification by Ebselen Reduces the Stability and Cellular Levels of 14-3-3 Proteins.
    Waløen K; Jung-Kc K; Vecchia ED; Pandey S; Gasparik N; Døskeland A; Patil S; Kleppe R; Hritz J; Norton WHJ; Martinez A; Haavik J
    Mol Pharmacol; 2021 Aug; 100(2):155-169. PubMed ID: 34031189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic binding of the phosphorylated S233- and S259-binding sites of C-RAF to one 14-3-3ζ dimer.
    Molzan M; Ottmann C
    J Mol Biol; 2012 Nov; 423(4):486-95. PubMed ID: 22922483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of 14-3-3γ to membranes studied by intrinsic fluorescence spectroscopy.
    Bustad HJ; Underhaug J; Halskau O; Martinez A
    FEBS Lett; 2011 Apr; 585(8):1163-8. PubMed ID: 21420405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of an intra-chain tandem 14-3-3 binding site within PKCepsilon.
    Kostelecky B; Saurin AT; Purkiss A; Parker PJ; McDonald NQ
    EMBO Rep; 2009 Sep; 10(9):983-9. PubMed ID: 19662078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.